Please login to the form below

Not currently logged in
Email:
Password:

ASCO

This page shows the latest ASCO news and features for those working in and with pharma, biotech and healthcare.

Roche builds on Immunocore ImmTAC deal

Roche builds on Immunocore ImmTAC deal

Immuncore's lead in-house project, IMCgp100, is in pivotal studies for uveal melanoma, and encouraging phase 1 data was presented at ASCO earlier this year.

Latest news

More from news
Approximately 22 fully matching, plus 116 partially matching documents found.

Latest Intelligence

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    Nektar Therapeutics’CD122 agonist NKTR-214 posted mixed results in mid-stage trials alongside Opdivo in solid tumours at the American Society of Clinical Oncology (ASCO) meeting this year that disappointed ... ASCO last year, and a larger, 1,

  • Bluebird Bio: on the cusp of a gene therapy revolution Bluebird Bio: on the cusp of a gene therapy revolution

    On 1 June it presented data on bb2121 at ASCO which showed the therapy could stop the disease in its tracks in the sickest patients, where all other treatments had failed.

  • No incentive for a cure No incentive for a cure

    The systems we have -. from the ICER Value Assessment Framework to the ASCO Value Framework - are often at odds with each other, and none of them wholly addresses all the attributes

  • Avoiding data pitfalls in clinical research Avoiding data pitfalls in clinical research

    Meeting of the American Society of Clinical Oncology (ASCO). ... The pilot was successful enough to be accepted for presentation at the ASCO’s Annual Meeting, the largest academic cancer conference in the world.

  • Are we #winning? Are we #winning?

    We’ve seen multiple online ‘TV’channels launch from medical societies and congress; some (eg ASCO) have commoditised their assets, and - for example, with Novartis’VivindaTV.com - pharma is now competing

More from intelligence
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest from PMHub

  • Artificial Intelligence in Healthcare

    Poster presented at: 2017 American Society of Clinical Oncology (ASCO) Annual Meeting; June 3, 2017; Chicago, IL.

  • How did pharma use Twitter at #ASCO16?

    How did pharma use Twitter at #ASCO16? Each year, ASCO’ s Annual Meeting brings together 30, 000 oncology professionals from around the world, here we explore the #ASCO16 hashtag and how ... ASCO’ s Annual Meeting has led the way in terms of social

  • ASCO 2015: What you missed in Chicago

    Three monoclonal antibodies were presented on the last day of ASCO - two in multiple myeloma and one in amyloidosis. ... ASCO 15: Highlighting innovation and raising key questions. Amgen and AstraZeneca had excellent booths that were extremely

  • Ashfield

    Each year, ASCO’ s Annual Meeting brings together 30, 000 oncology professionals from around the world, here we explore the #ASCO16 hashtag and how pharma utilised the channel during this

  • Ashfield

    Each year, ASCO’ s Annual Meeting brings together 30, 000 oncology professionals from around the world, here we explore the #ASCO16 hashtag and how pharma utilised the channel during this

More from PMHub
Approximately 2 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics